This page includes the latest FDA filings for Hainan Shuangcheng Pharmaceuticals Co L T D. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
CHINA | SHENZHEN STOCK EXCHANGE | 002693 | DUNS 421282282 |
Device Company | Device | Date |
---|---|---|
Hainan Shuangcheng Pharmaceuticals Co., Ltd. | Prescription Medication | 2024-12-24 |
Hainan Shuangcheng Pharmaceuticals Co., Ltd. | Prescription Medication | 2024-12-22 |
Hainan Shuangcheng Pharmaceuticals Co., Ltd. | Prescription Medication | 2024-12-20 |
Hainan Shuangcheng Pharmaceuticals Co., Ltd. | Prescription Medication | 2022-04-23 |
Hainan Shuangcheng Pharmaceuticals Co., Ltd. | Eptifibatide | 2022-04-21 |
Hainan Shuangcheng Pharmaceuticals Co., Ltd. | Prescription Medication | 2021-11-26 |
Hainan Shuangcheng Pharmaceuticals Co., Ltd. | Eptifibatide | 2021-09-07 |
Hainan Shuangcheng Pharmaceuticals Co., Ltd. | Prescription Medication | 2020-12-18 |
Hainan Shuangcheng Pharmaceuticals Co., Ltd. | Prescription Medication | 2019-10-29 |
Hainan Shuangcheng Pharmaceuticals Co., Ltd. | 2019-10-28 | |
Hainan Shuangcheng Pharmaceuticals Co., Ltd. | Bivalirudin | 2019-10-28 |
Hainan Shuangcheng Pharmaceuticals Co., Ltd. | 2012-07-31 |